Drug Trial Radar · NCT07234864
Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients.
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Nov 19, 2025
Primary completion
Apr 21, 2026
Study completion Jul 9, 2026
Sponsor
- Lead sponsor
- Eilean TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Nov 19, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 1b study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of multiple doses of ZE63-0302 administrated orally in T2DM patients.
Conditions
- Type 2 Diabetes
Interventions
ZE63-0302Drug
Oral capsules BID
PlaceboDrug
Oral capsules BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of AE/SAE.Time frame: From dosing to Week 4.
- Change from baseline throughout the study in the vital signs and physical examination findings.Time frame: From dosing to Week 4.
- Change from baseline throughout the study in 12-lead electrocardiogram resultsTime frame: From dosing to Week 4
- Change from baseline throughout the study in Clinical laboratory assessments.Time frame: From dosing to Week 4.
Locations
10 sites in 3 countries. Site status is shown where the registry gives one.
Emeritus Research Sydney
Botany, New South Wales, Australia
Momentum Clinical Research Taringa
Brisbane, Queensland, Australia
Momentum Clinical Research Sunshine
Melbourne, Victoria, Australia
Emeritus Research Camberwell
Melbourne, Victoria, Australia
PCRN Rotorua
Rotorua, Bay of Plenty, New Zealand
PCRN Christchurch
Christchurch, Canterbury, New Zealand
Momentum Dunedin
Dunedin, Otago, New Zealand
PCRN Waikato
Hamilton, Waikato Region, New Zealand
Momentum Wellington
Wellington, Wellington Region, New Zealand
The Republican Specialized Scientific and Prectical Medical Center of Endocrinology named after Academician Yo. Kh. Turakulov
Tashkent, Tashkent, Uzbekistan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.